A HIGHLY effective drug which can cure Hepatitis C hit the market in 2013 but five years later, over 70 million people around the world are still not getting the needed treatment.
In Malaysia, that was initially the fate of an estimated 400,000 patients for this disease, amid intense debates whether the cheaper generic version of drugs should be made available to more people.
